Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

European Research Council grant · Running

MicrobiotaNeuroTalk Trafficking mechanisms and physiological factors mediating a direct gut microbiota-brain neuron interaction

Coordinator
Fundacao Gimm - Gulbenkian Institute for Molecular Medicine, Portugal
Runs
1 December 2023 to 31 May 2029
Status
Running
EU funding
€1.9m
Total cost
€1.9m
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101116569

What the project is doing

In the project's own words, from its summary on CORDIS.

The gut-brain axis has emerged as a complex regulator of system-wide physiology, playing essential roles to maintain homeostasis, including contributions to brain development and activity, affecting host metabolism and behavior. The gut bacterial composition constantly fluctuates, allowing for the regular release of diverse microbe-derived compounds into the bloodstream. Although it is known that many gut-bacterial metabolites affect distant organs such as the brain, their direct interaction with brain neurons is rarely demonstrated.

The impact of microbial metabolites on brain mechanisms are generally thought to be indirect due to interaction with, for example, the immune system or the vagus nerve. However, my previous work has shown that microbe-derived muropeptides reach the brain and decrease the spontaneous activity of brain neurons that express the Nod2 receptor. Remarkably, this direct interaction affected appetite and thermoregulation in a sex- and age-dependent fashion.

Nevertheless, to further understand these direct interactions, some questions still need to be addressed: how does this compound reach the brain? Which factors may lead to this sex- and age-dependent neuronal activation? Are there other neuroactive bacterial compounds directly affecting brain neurons? Therefore, using interdisciplinary approaches, I propose to (1) unravel gut-brain trafficking mechanisms, (2) define physiological factors (e.g. hormones) that shape this microbe-neuron interaction and (3) describe new bacterial compounds that affect hypothalamic circuits and their downstream effects.

This proposal will expose novel aspects of host-microbe interactions, leading to a more complete and integrated understanding of bacterial influence on host’s essential functions. It may also lead to new therapeutic approaches for neurological disorders that exhibit specific sex prevalence and where the microbiota is a factor in disease susceptibility, such as Alzheimer’s and Parkinson’s diseases.

Who is involved

OrganisationCityCountryRole
Fundacao Gimm - Gulbenkian Institute for Molecular MedicineLisboaPortugalCoordinator
Fundacao Calouste GulbenkianLisboaPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI